Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-187-4 | CAS number: 135-37-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From March 20, 1986 to May 22, 1986
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well documented study, followed guideline with deviation.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- (One dose level was tested against the guideline requirement of 3 dose levels; Only 1000 polychromatic erythrocytes/animal were examined for the presence of micronuclei against the guideline requirement of 2000 polychromatic erythrocytes/animal)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- (One dose level was tested against the guideline requirement of 3 dose levels; Only 1000 polychromatic erythrocytes/animal were examined for the presence of micronuclei against the guideline requirement of 2000 polychromatic erythrocytes/animal)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Disodium 2-hydroxyethyliminodi(acetate)
- EC Number:
- 205-187-4
- EC Name:
- Disodium 2-hydroxyethyliminodi(acetate)
- Cas Number:
- 135-37-5
- Molecular formula:
- C6H9NO5.Na2
- IUPAC Name:
- disodium 2-hydroxyethyliminodi(acetate)
- Reference substance name:
- 2,2'-[(2-hydroxyethyl)imino]diacetic acid, disodium salt
- IUPAC Name:
- 2,2'-[(2-hydroxyethyl)imino]diacetic acid, disodium salt
- Test material form:
- not specified
- Details on test material:
- - Name of test material: Hydroxyethyliminodiacetic acid, disodium salt
- TSIN: E-2748.03
- Substance type: Pure active substance
- Solubility: Soluble in water
Constituent 1
Constituent 2
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Obtained from Charles River U.K. Limited, Margate, Kent, Englandon 7, 14 and 27 March 1986
- Age at study initiation: 3 - 4weeks old
- Weight at study initiation: 18 to 21 grams (on arrival)
- Assigned to test groups randomly: Yes
- Fasting period before study: Animals were fasted "overnight" prior to dosing
- Housing: Animals of both sexes were housed separately in groups of 2 or 5 in plastic disposable cages.
- Diet: Scientific Feeds rodent diet LAD-1 was provided ad libitum except during the overnight fasting period prior to dosing
- Water: tap water, ad libitum
- Acclimation period: 10 days
ENVIRONMENTAL CONDITIONS
- Temperature : 22 °C
- Humidity : Not reported
- Air changes: 30 air changes per hour
- Photoperiod : 12 hours dark/12 hours artificial light
EXPERIMENT INITIATION DATE: March 20, 1986
EXPERIMENT COMPLETION DATE: May 22, 1986
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle used: Deionised water
- Concentration of test material in vehicle: 97.2 mg/mL
- Amount of vehicle : 16 mL/kg bw - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: Solutions of test substance were prepared just prior to use in deionised water.
- Duration of treatment / exposure:
- 48 h
- Frequency of treatment:
- Single treatment
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1555.2 mg /kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- Vehicle control and test group: 15 animals/sex
Positive control group: 5 animals/sex - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Mitomycin C
- Route of administration: Oral gavage (intragastric gavage)
- Doses / concentrations: 8 mg mitomycin C/kg bw . It was prepared as a solution in sterile 0.9% saline at a concentration of 0.5 mg/mL.
Examinations
- Tissues and cell types examined:
- Tissue: Femoral bone marrow
Cell types: Polychromatic erythrocytes - Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: The dose for the micronucleus test was based on a preliminary toxicity test. Details are provided on the study report
TREATMENT AND SAMPLING TIMES: Bone marrow was collected from the negative control and test treatment group at 18, 24 and 48 h post dosing. 5 animals/sex were sacrificed at each sampling time.. A sampling time of 24 hours was used for the positive control group.
DETAILS OF SLIDE PREPARATION: Animals were killed by cervical dislocation and both femurs dissected out from each animal. A direct smear of bone marrow was made onto a slide containing a drop of calf serum. One smear was prepared from each femur. The prepared smears were air-dried and fixed in methanol. After fixation, the smears were air-dried and stained in Giemsa's stain, rinsed in pH 6.8 buffered distilled water, air-dried, and mounted with coverslips.
METHOD OF ANALYSIS: Coded slides were examined by light microscopy and 1000 polychromatic erythrocytes per animal were examined for the presence of micronuclei. The ratio of polychromatic to normochromatic erythrocytes was assessed by examination of at least 1000 erythrocytes per animal. The results for the treated group were compared with the results obtained with the concurrent vehicle control group using non-parametric statistical methods. - Evaluation criteria:
- A positive result was defined as follows: either a statistically significant dose-related increase or a reproducible and statistically significant positive response for at least one of the dose levels was obtained.
- Statistics:
- The results obtained for the treatment group in the main test were compared with the results obtained with the concurrent vehicle control group using non-parametric statistical methods (e.g., Wilcoxon's sum of ranks test). In the preliminary toxicity test, the mortality data were subjected to a probit analysis.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- (Slight piloerection and slight hunched posture were observed between 30 minutes and 2 hours post-dosing.)
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
The results of the preliminary study indicated that a dosage of 1555.2 mg/kg bw would be expected to kill approximately 1% of the animals within 6 days of dosing. Details are provided in the study report.
RESULTS OF DEFINITIVE STUDY
- Signs and mortalities: No animals died after treatment with the test substance in the main study. Clinical signs such as pilo-erection and hunched posture were observed at 30 min, 1 and 2 h post-dosing.
- Induction of micronuclei (for Micronucleus assay): At the 24 hour sampling time slight, but just statistically significant (p=0.045 using Wilcoxon's sum of ranks test) increases in the number of micronucleated polychromatic erythrocytes were reported in test substance-treated animals. The individual values for this group were within the laboratory historical control range and the group mean was comparable with the historical control mean. Consequently these increases were not considered to be evidence of a treatment-related effect. At the 18 and 48 hour sampling times, no such significant increases were reported. Also, the test substance did not cause any substantial increases in the incidence of micronucleated normochromatic erythrocytes at any of the three kill times.
- Ratio of PCE/NCE: The test substance failed to cause any significant decreases in the ratio of polychromatic to normochromatic erythrocytes (p>0.05 using Wilcoxon's sum of ranks test).
RESULTS OF POSITIVE CONTROL
- Positive control caused large, highly significant increases in the frequency of micronucleus polychromatic erythrocytes after 24 h exposure (P<0.001). Also, it did not significantly decrease the polychromatic to normochromatic erythrocytes ratio at the 24 h sampling time (P>0.05).
- Statistical evaluation: Non-parametric statistical methods (e.g., Wilcoxon's sum of ranks test, 1-sided probabilities) were used to compare results of treated group with results obtained with the concurrent vehicle control group.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
Hydroxyethyliminodiacetic acid when administered orally at 1555.2 mg /kg bw was non-mutagenic in the micronucleus test with bone marrow cells of the mouse. - Executive summary:
The purpose of this study was to assess the mutagenic potential of Hydroxyethyliminodiacetic acid in the micronucleus assay. The study was performed according to OECD guideline 474 and EU Method B.12.
CD-1 male and female mice weighing 18 to 21 grams from Charles River U.K. Limited, Margate, Kent, England were acclimated for 10 d. The food used was Scientific Feeds rodent diet LAD-1 (ad libitum). The animals of both sexes were housed separately in groups of 2 or 5 in plastic disposable cages and maintained under standard laboratory conditions (temperature: 22 °C; artificial light: 12-h cycle; Air changes: 30 air changes per hour).15 animals/sex were used in the test and vehicle group while 5 animals/sex were employed in positive control group.
The test substance was prepared in deionised water, which was also used as vehicle control. 1555.2 mg/kg bw of test substance (dose volume: 16 mL/kg bw) was administered to 15 animals/sex. This dose level was estimated from pre-experiment.
Positive control, Mitomycin C (8 mg/kg bw.), was administered orally to 5 animals/sex.
Bone marrow was collected from the negative control and test treatment group at 18, 24 and 48 h post dosing. 5 animals/sex were sacrificed per sampling time. A sampling time of 24 h was used for the positive control group.
At the 24-hour sampling time, slight statistically significant (p = 0.045, using Wilcoxon’s sum of ranks test) increases in the number of micronucleated polychromatic erythrocytes were observed in test substance-treated animals. The individual animal values for this group were within the laboratory historical control range and the group mean was comparable with the historical control mean. Consequently, these increases were not considered to be evidence of a treatment-related effect. At the 18and 48h sampling times, no such significant increases were obtained. The test substance did not cause any substantial increases in the incidence of micronucleated normochromatic erythrocytes at any of the three sampling times.
The positive control, Mitomycin C, caused highly significant increases in the frequency of micronucleus polychromatic erythrocytes after 24 h exposure (P<0.001).
In conclusion, Hydroxyethyliminodiacetic acid when administered orally at 1555.2 mg /kg bw was non-mutagenic in the micronucleus test with bone marrow cells of the mouse.
This Mammalian Erythrocyte Micronucleus Test is classified as acceptable, and satisfies the guideline requirements of the OECD 474 method.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.